New Classifications of Five Distinct “Sleep” Profi... ...
A Professional Overview of Hypertension ...
High-speed imaging tracks live brain cell activity...
Drug candidate slows motor neuron disease progress...
Drug candidate slows motor neuron disease progress...
Mark Cuban: A Master Disrupter for American Health...
Superbugs on your plate: How antimicrobial resistance spread...
June 13,2026
Can marijuana cause lung cancer?...
June 12,2026
Standard depression screening could be missing key symptoms ...
June 11,2026
More women are having babies later in life. How to improve y...
June 10,2026
For severe babesiosis, red blood cell exchange is associated...
June 09,2026
Cause or effect? Study answers question about gene linked wi...
June 08,2026
Category
Traditional Medicine
Q & A
Wellness
Drug Discovery
Technology & AI
Clinical Pearl Series
Breakthroughs
Immunology & Rheumatology
Reproduction
Hepatobiliary&Pancreas Surgery
Most Read
Blood Pressure Chart With Readings By Age and Sex

Blood Pressure Chart With Readings By Age and Sex

Blood Pressure Chart With Readings By Age and SexAverage Ranges Show Normal Pressure On the ArteriesBySheryl Huggins SalomonUpdated on April 21, 2023Medically reviewed byJeffre
Cardiovascular Diseases April 07,2024
Blood Pressure Chart With Readings By Age and Sex

Blood Pressure Chart With Readings By Age and Sex

Blood Pressure Chart With Readings By Age and SexAverage Ranges Show Normal Pressure On the ArteriesBySheryl Huggins SalomonUpdated on April 21, 2023Medically reviewed byJeffre
Cardiovascular Diseases April 07,2024
Pelage Pharmaceuticals Advances Hair Loss Treatment with Phase 2 Study and $14M Funding

Pelage Pharmaceuticals Advances Hair Loss Treatment with Phase 2 Study and $14M Funding

Pelage Pharmaceuticals has commenced dosing the first patients in its Phase 2a clinical trial for PP405, a novel topical treatment designed to reactivate dormant hair follicle stem cells.
Dermatology August 14,2024
Pelage Pharmaceuticals Advances Hair Loss Treatment with Phase 2 Study and $14M Funding

Pelage Pharmaceuticals Advances Hair Loss Treatment with Phase 2 Study and $14M Funding

Pelage Pharmaceuticals has commenced dosing the first patients in its Phase 2a clinical trial for PP405, a novel topical treatment designed to reactivate dormant hair follicle stem cells.
Dermatology August 14,2024
Blood Types: What Letters, Positive, and Negative Signs Mean

Blood Types: What Letters, Positive, and Negative Signs Mean

Blood Types: What Letters, Positive, and Negative Signs MeanWhat to Know About Your Blood TypeByNancy LeBrunPublished on September 15, 2023Medically reviewed byAnju Goel, MDYou
Oncology March 17,2024
Blood Types: What Letters, Positive, and Negative Signs Mean

Blood Types: What Letters, Positive, and Negative Signs Mean

Blood Types: What Letters, Positive, and Negative Signs MeanWhat to Know About Your Blood TypeByNancy LeBrunPublished on September 15, 2023Medically reviewed byAnju Goel, MDYou
Oncology March 17,2024
Today's News
Eye Infections (Updated) | Clinical Medicine...
Announcement of the 2025 Nobel Prize in ...
Dr. Fauci among hundreds who've contract...
Why are young, healthy adults experienci...
Reprogramming Stem Cells Could Cure Type...
More News
Unveiling cellular composition and spatial architecture of tumor microenvironment in multiple primary lung cancers

Unveiling cellular composition and spatial architecture of tumor microenvironment in multiple primary lung cancers

by Li Yuan,Chinese Academy of SciencesThe cellular and molecular profiles of different histologic patterns in MPLC-LUAD. a Pathological classification of malignant regions into histologic patter
World medicine December 10,2023
Unveiling cellular composition and spatial architecture of tumor microenvironment in multiple primary lung cancers

Unveiling cellular composition and spatial architecture of tumor microenvironment in multiple primary lung cancers

by Li Yuan,Chinese Academy of SciencesThe cellular and molecular profiles of different histologic patterns in MPLC-LUAD. a Pathological classification of malignant regions into histologic patter
World medicine December 10,2023
Uncovering cancer-immune system interactions could inform how patients respond to immunotherapy

Uncovering cancer-immune system interactions could inform how patients respond to immunotherapy

byThe Francis Crick InstituteThe researchers described a mechanism in head and neck cancers that promotes high immune infiltration by suppressing ‘keratinisation‘ which usually inhibits immune c
World medicine December 10,2023
Uncovering cancer-immune system interactions could inform how patients respond to immunotherapy

Uncovering cancer-immune system interactions could inform how patients respond to immunotherapy

byThe Francis Crick InstituteThe researchers described a mechanism in head and neck cancers that promotes high immune infiltration by suppressing ‘keratinisation‘ which usually inhibits immune c
World medicine December 10,2023
Uncovering the role of KDM6A in epigenetic regulation of subtype plasticity in small cell lung cancer

Uncovering the role of KDM6A in epigenetic regulation of subtype plasticity in small cell lung cancer

byDana-Farber Cancer InstituteKDM6A inactivation in an autochthonous SCLC mouse model promotes NEUROD1 expression leading to SCLC tumors that express both ASCL1 and NEUROD1. a, Schematic of the
World medicine December 10,2023
Uncovering the role of KDM6A in epigenetic regulation of subtype plasticity in small cell lung cancer

Uncovering the role of KDM6A in epigenetic regulation of subtype plasticity in small cell lung cancer

byDana-Farber Cancer InstituteKDM6A inactivation in an autochthonous SCLC mouse model promotes NEUROD1 expression leading to SCLC tumors that express both ASCL1 and NEUROD1. a, Schematic of the
World medicine December 10,2023
Unlocking the mystery of long-lasting cancer treatment

Unlocking the mystery of long-lasting cancer treatment

byUniversity College LondonCredit: Unsplash/CC0 Public DomainNew insights explaining why some children have a longer remission than others after having cutting-edge CAR T-cell therapy for leukem
World medicine December 10,2023
Unlocking the mystery of long-lasting cancer treatment

Unlocking the mystery of long-lasting cancer treatment

byUniversity College LondonCredit: Unsplash/CC0 Public DomainNew insights explaining why some children have a longer remission than others after having cutting-edge CAR T-cell therapy for leukem
World medicine December 10,2023
AML patients receiving vitamin C/D supplements found to have fewer complications, but no overall survival benefit

AML patients receiving vitamin C/D supplements found to have fewer complications, but no overall survival benefit

byAmerican Society of HematologyCredit: Pixabay/CC0 Public DomainPatients with acute myeloid leukemia (AML) who received vitamin C and D supplements while undergoing intensive chemotherapy had l
World medicine December 10,2023
AML patients receiving vitamin C/D supplements found to have fewer complications, but no overall survival benefit

AML patients receiving vitamin C/D supplements found to have fewer complications, but no overall survival benefit

byAmerican Society of HematologyCredit: Pixabay/CC0 Public DomainPatients with acute myeloid leukemia (AML) who received vitamin C and D supplements while undergoing intensive chemotherapy had l
World medicine December 10,2023
Veterans exposed to Agent Orange may be at increased risk of developing progressive blood cancers

Veterans exposed to Agent Orange may be at increased risk of developing progressive blood cancers

byGeorgetown University Medical CenterCredit: Pixabay/CC0 Public DomainResearch conducted at Georgetown University's Lombardi Comprehensive Cancer Center and the Washington DC VA Medical Cen
World medicine December 10,2023
Veterans exposed to Agent Orange may be at increased risk of developing progressive blood cancers

Veterans exposed to Agent Orange may be at increased risk of developing progressive blood cancers

byGeorgetown University Medical CenterCredit: Pixabay/CC0 Public DomainResearch conducted at Georgetown University's Lombardi Comprehensive Cancer Center and the Washington DC VA Medical Cen
World medicine December 10,2023
Exposure to Agent Orange linked to risk of bladder cancer

Exposure to Agent Orange linked to risk of bladder cancer

by Elana GotkineExposure to Agent Orange is associated with a small but significantly increased risk of bladder cancer among male Vietnam veterans, according to a study published online June 27 in&nbs
World medicine December 10,2023
Exposure to Agent Orange linked to risk of bladder cancer

Exposure to Agent Orange linked to risk of bladder cancer

by Elana GotkineExposure to Agent Orange is associated with a small but significantly increased risk of bladder cancer among male Vietnam veterans, according to a study published online June 27 in&nbs
World medicine December 10,2023
Blood pressure medication combined with chemotherapy could reduce spread in triple negative breast cancer

Blood pressure medication combined with chemotherapy could reduce spread in triple negative breast cancer

byMonash UniversityNerve. Credit: Monash UniversityA new international study led by Monash University has, for the first time, identified that beta-blockers could significantly enhance the thera
World medicine December 10,2023
Blood pressure medication combined with chemotherapy could reduce spread in triple negative breast cancer

Blood pressure medication combined with chemotherapy could reduce spread in triple negative breast cancer

byMonash UniversityNerve. Credit: Monash UniversityA new international study led by Monash University has, for the first time, identified that beta-blockers could significantly enhance the thera
World medicine December 10,2023
Putting the STING into cancer immunotherapy

Putting the STING into cancer immunotherapy

by Bendta Schroeder,Massachusetts Institute of TechnologyBelcher and Hammond Lab researchers developed a cancer vaccine that could make checkpoint blockade therapies more effective for more pati
World medicine December 10,2023
Putting the STING into cancer immunotherapy

Putting the STING into cancer immunotherapy

by Bendta Schroeder,Massachusetts Institute of TechnologyBelcher and Hammond Lab researchers developed a cancer vaccine that could make checkpoint blockade therapies more effective for more pati
World medicine December 10,2023
Including women in their 40s in breast cancer screening programs beneficial

Including women in their 40s in breast cancer screening programs beneficial

by Elana GotkineScreening programs that include women in their 40s are associated with significantly higher breast cancer (BC) 10-year net survival (NS) for women aged 40 to 49 years, according to a s
World medicine December 10,2023
Including women in their 40s in breast cancer screening programs beneficial

Including women in their 40s in breast cancer screening programs beneficial

by Elana GotkineScreening programs that include women in their 40s are associated with significantly higher breast cancer (BC) 10-year net survival (NS) for women aged 40 to 49 years, according to a s
World medicine December 10,2023
More News
Week’s Top
Podcasts
... Preparing for a tough exam? A tough gym workout could help with your studies ... ... GOSH BRC Showcase 2025 - Genomic medicine ... ... Brain activity goes to extremes in soccer fans, neuroimaging reveals ...
FIND US ON
ABOUT
Who We Are
Contact Us
Editorial Team
Sitemap
Policy
Privacy Policy
Advertising Policy
Editorial Policy
Corrections Policy
Medical Disclaimer
Alliance
wmo.com
sleep.net
pharm.net
doctors.net
worldsleep.com